Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.

PubWeight™: 3.08‹?› | Rank: Top 1%

🔗 View Article (PMID 18376402)

Published in Nat Immunol on March 30, 2008

Authors

Sven Burgdorf1, Christian Schölz, Andreas Kautz, Robert Tampé, Christian Kurts

Author Affiliations

1: Institute of Molecular Medicine and Experimental Immunology, Friedrich-Wilhelms University, 53105 Bonn, Germany. sven.burgdorf@ukb.uni-bonn.de

Articles citing this

(truncated to the top 100)

Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Cancer Cell (2010) 3.52

Pathways of antigen processing. Annu Rev Immunol (2013) 2.82

Cross-priming in health and disease. Nat Rev Immunol (2010) 2.51

A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells. Immunity (2009) 1.82

Oncolytic viruses: a novel form of immunotherapy. Expert Rev Anticancer Ther (2008) 1.78

Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc Natl Acad Sci U S A (2009) 1.46

DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol (2011) 1.42

Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J Exp Med (2009) 1.42

Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest (2011) 1.33

Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med (2012) 1.32

Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res (2011) 1.30

Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A (2009) 1.29

MHC class I assembly: out and about. Trends Immunol (2008) 1.29

Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc Natl Acad Sci U S A (2010) 1.25

Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A (2009) 1.24

CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake. J Immunol (2012) 1.24

Immune mechanisms of protection: can adjuvants rise to the challenge? BMC Biol (2010) 1.22

ABC proteins in antigen translocation and viral inhibition. Nat Chem Biol (2010) 1.22

HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC. Eur J Immunol (2010) 1.18

Proteases in MHC class I presentation and cross-presentation. J Immunol (2010) 1.15

Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol (2012) 1.15

Designing CD8+ T cell vaccines: it's not rocket science (yet). Curr Opin Immunol (2010) 1.13

The endosome-lysosome pathway and information generation in the immune system. Biochim Biophys Acta (2011) 1.08

Impact of aging on dendritic cell functions in humans. Ageing Res Rev (2010) 1.08

Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol (2013) 1.07

CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. J Clin Invest (2012) 1.07

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants? Trends Immunol (2013) 1.05

Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc Natl Acad Sci U S A (2011) 1.05

Tumor evasion from T cell surveillance. J Biomed Biotechnol (2011) 1.01

An updated view of the intracellular mechanisms regulating cross-presentation. Front Immunol (2013) 1.01

Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1. PLoS One (2014) 1.00

Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells. Oncoimmunology (2012) 0.98

Presentation of phagocytosed antigens by MHC class I and II. Traffic (2012) 0.98

The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity. J Immunol (2010) 0.97

B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes (2012) 0.96

Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology (2011) 0.96

Cross-presentation: how to get there - or how to get the ER. Front Immunol (2012) 0.95

T cells and dendritic cells in glomerular disease: the new glomerulotubular feedback loop. Kidney Int (2009) 0.95

The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1. J Immunother (2012) 0.94

Escape from the Phagosome: The Explanation for MHC-I Processing of Mycobacterial Antigens? Front Immunol (2012) 0.94

TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation. J Immunol (2011) 0.93

Intracellular events regulating cross-presentation. Front Immunol (2012) 0.93

Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev (2012) 0.93

Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. Front Immunol (2014) 0.93

Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations. Front Immunol (2012) 0.93

Cross-presentation: avoiding trafficking chaos? Nat Immunol (2008) 0.93

Adeno-associated virus capsid antigen presentation is dependent on endosomal escape. J Clin Invest (2013) 0.92

Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell. J Mol Med (Berl) (2011) 0.92

The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol (2011) 0.92

Dendritic cell-based vaccines: barriers and opportunities. Future Oncol (2012) 0.91

A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity. Cancer Res (2013) 0.91

Plasmacytoid dendritic cells in HIV infection. Adv Exp Med Biol (2013) 0.90

Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice. J Immunol (2010) 0.90

Into the intracellular logistics of cross-presentation. Front Immunol (2012) 0.90

Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development. Mem Inst Oswaldo Cruz (2011) 0.90

Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett (2012) 0.89

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol (2014) 0.89

Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines. Front Immunol (2014) 0.89

How to connect an IgE-driven response with CTL activity? Cancer Immunol Immunother (2011) 0.89

A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen. EMBO Rep (2011) 0.88

The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools. Cancer Immunol Immunother (2012) 0.88

The role of insulin-regulated aminopeptidase in MHC class I antigen presentation. Front Immunol (2012) 0.88

Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. ACS Nano (2013) 0.88

Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS One (2010) 0.87

Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity. PLoS One (2012) 0.87

Role of CD8(+)T cells in the host response to Chlamydia. Microbes Infect (2008) 0.87

Steady-state cross-presentation of OVA is mannose receptor-dependent but inhibitable by collagen fragments. Proc Natl Acad Sci U S A (2010) 0.87

SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines. Cancer Res (2014) 0.87

Natural splice variant of MHC class I cytoplasmic tail enhances dendritic cell-induced CD8+ T-cell responses and boosts anti-tumor immunity. PLoS One (2011) 0.87

The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells. Proc Natl Acad Sci U S A (2009) 0.87

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy. J Immunol (2012) 0.87

New generation of dendritic cell vaccines. Hum Vaccin Immunother (2013) 0.86

Specific lipids modulate the transporter associated with antigen processing (TAP). J Biol Chem (2011) 0.86

Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention. Clin Exp Immunol (2011) 0.85

Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo. J Immunol (2014) 0.85

Direct visualization of peptide/MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major. PLoS Pathog (2010) 0.85

Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity. J Invest Dermatol (2010) 0.85

Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells. J Immunol (2009) 0.84

Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes. Cancer Immunol Immunother (2010) 0.84

Analysis of phagosomal proteomes: from latex-bead to bacterial phagosomes. Proteomics (2010) 0.84

Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells. EBioMedicine (2016) 0.84

Targeting TLR2 for vaccine development. J Immunol Res (2014) 0.83

Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity. J Control Release (2011) 0.83

Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells. Infect Immun (2008) 0.83

Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets. Front Immunol (2015) 0.83

Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response. Cell Rep (2015) 0.82

Intracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-Presentation. Front Immunol (2015) 0.82

Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice. PLoS One (2012) 0.81

Tubulation of endosomal structures in human dendritic cells by Toll-like receptor ligation and lymphocyte contact accompanies antigen cross-presentation. J Biol Chem (2013) 0.81

Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical models. PLoS One (2013) 0.81

Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells. PLoS One (2012) 0.81

Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells. J Immunol (2014) 0.80

Autophagy creates a CTL epitope that mimics tumor-associated antigens. PLoS One (2012) 0.80

Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications. Front Immunol (2016) 0.80

IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses. Cell Rep (2015) 0.80

The comings and goings of MHC class I molecules herald a new dawn in cross-presentation. Immunol Rev (2016) 0.80

Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS One (2014) 0.79

Oxidized phagosomal NOX2 complex is replenished from lysosomes. J Cell Sci (2017) 0.78

Mannosylation of virus-like particles enhances internalization by antigen presenting cells. PLoS One (2014) 0.78

Articles by these authors

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science (2007) 3.27

Acetyl-phosphate is a critical determinant of lysine acetylation in E. coli. Mol Cell (2013) 2.65

Dynamic superresolution imaging of endogenous proteins on living cells at ultra-high density. Biophys J (2010) 2.65

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood (2013) 2.34

Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol (2004) 2.18

Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep (2013) 2.15

Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology (2011) 2.14

The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol (2006) 2.09

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci U S A (2003) 2.09

The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol (2009) 2.06

High-affinity adaptors for switchable recognition of histidine-tagged proteins. J Am Chem Soc (2005) 2.06

Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest (2009) 2.01

The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med (2009) 1.95

Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol (2004) 1.94

Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med (2002) 1.89

The renal mononuclear phagocytic system. J Am Soc Nephrol (2011) 1.84

Structure and mechanism of ABC transporters. Curr Opin Struct Biol (2002) 1.84

Stochastic sensing of proteins with receptor-modified solid-state nanopores. Nat Nanotechnol (2012) 1.82

Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol (2010) 1.81

Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol (2008) 1.70

Integrins β1 and β3 exhibit distinct dynamic nanoscale organizations inside focal adhesions. Nat Cell Biol (2012) 1.66

Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics (2012) 1.62

Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci U S A (2009) 1.61

Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J Immunol (2010) 1.59

Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens. J Am Soc Nephrol (2013) 1.54

Specific and stable fluorescence labeling of histidine-tagged proteins for dissecting multi-protein complex formation. J Am Chem Soc (2006) 1.53

The ATP hydrolysis cycle of the nucleotide-binding domain of the mitochondrial ATP-binding cassette transporter Mdl1p. J Biol Chem (2003) 1.52

The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) (2004) 1.51

Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). J Biol Chem (2003) 1.42

Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat Methods (2012) 1.40

Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol (2008) 1.38

Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol (2013) 1.37

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (2005) 1.36

Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol Syst Biol (2014) 1.35

The transporter associated with antigen processing: function and implications in human diseases. Physiol Rev (2002) 1.33

CCR2 mediates homeostatic and inflammatory release of Gr1(high) monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. J Immunol (2008) 1.28

Structural arrangement of the transmission interface in the antigen ABC transport complex TAP. Proc Natl Acad Sci U S A (2009) 1.27

Ribosome recycling depends on a mechanistic link between the FeS cluster domain and a conformational switch of the twin-ATPase ABCE1. Proc Natl Acad Sci U S A (2011) 1.26

Fabs enable single particle cryoEM studies of small proteins. Structure (2012) 1.25

Purification and reconstitution of the antigen transport complex TAP: a prerequisite for determination of peptide stoichiometry and ATP hydrolysis. J Biol Chem (2009) 1.24

Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect Immun (2006) 1.23

In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye. Invest Ophthalmol Vis Sci (2008) 1.22

Structural organization of essential iron-sulfur clusters in the evolutionarily highly conserved ATP-binding cassette protein ABCE1. J Biol Chem (2007) 1.22

ABC proteins in antigen translocation and viral inhibition. Nat Chem Biol (2010) 1.22

Structural and functional fingerprint of the mitochondrial ATP-binding cassette transporter Mdl1 from Saccharomyces cerevisiae. J Biol Chem (2006) 1.18

Mitochondrial ABC proteins in health and disease. Biochim Biophys Acta (2009) 1.17

RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J (2012) 1.14

T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract. Nat Med (2010) 1.13

The kidney-renal lymph node-system contributes to cross-tolerance against innocuous circulating antigen. J Immunol (2008) 1.12

Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol (2007) 1.11

The binding specificity of OppA determines the selectivity of the oligopeptide ATP-binding cassette transporter. J Biol Chem (2004) 1.11

Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. Gastroenterology (2012) 1.11

High-affinity chelator thiols for switchable and oriented immobilization of histidine-tagged proteins: a generic platform for protein chip technologies. Chemistry (2005) 1.10

Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol (2009) 1.09

Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol (2005) 1.08

Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res (2012) 1.08

Peptides induce ATP hydrolysis at both subunits of the transporter associated with antigen processing. J Biol Chem (2003) 1.08

Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog (2008) 1.08

Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am J Pathol (2007) 1.07

Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol (2013) 1.07

Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J Am Soc Nephrol (2004) 1.07

Kidney dendritic cells in acute and chronic renal disease. Int J Exp Pathol (2010) 1.06

Functional non-equivalence of ATP-binding cassette signature motifs in the transporter associated with antigen processing (TAP). J Biol Chem (2004) 1.06

Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J Immunol (2008) 1.05

Kidney Dendritic Cells Become Pathogenic during Crescentic Glomerulonephritis with Proteinuria. J Am Soc Nephrol (2010) 1.05

Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II. J Allergy Clin Immunol (2009) 1.05

The MHC I loading complex: a multitasking machinery in adaptive immunity. Trends Biochem Sci (2013) 1.04

The role of chemokines and their receptors in dendritic cell biology. Front Biosci (2008) 1.03

Mechanism of substrate sensing and signal transmission within an ABC transporter: use of a Trojan horse strategy. J Biol Chem (2006) 1.03

Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol (2011) 1.02

Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney Int (2011) 1.01

CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol (2008) 1.01

How do ABC transporters drive transport? Biol Chem (2004) 1.01

Structure and dynamics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen-processing machinery. J Biol Chem (2006) 1.00

TNF-induced target cell killing by CTL activated through cross-presentation. Cell Rep (2012) 0.99

IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN. J Am Soc Nephrol (2012) 0.99

Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels. Channels (Austin) (2008) 0.99

CD81 is essential for the formation of membrane protrusions and regulates Rac1-activation in adhesion-dependent immune cell migration. Blood (2011) 0.99

The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J Biol Chem (2012) 0.98

Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. J Clin Invest (2013) 0.98

Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol (2013) 0.98

Intracellular peptide transporters in human--compartmentalization of the "peptidome". Pflugers Arch (2006) 0.98

Subtotal ablation of parietal epithelial cells induces crescent formation. J Am Soc Nephrol (2012) 0.98

Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1. J Immunol (2009) 0.97

Native protein nanolithography that can write, read and erase. Nat Nanotechnol (2007) 0.97

Selective and ATP-dependent translocation of peptides by the homodimeric ATP binding cassette transporter TAP-like (ABCB9). J Biol Chem (2005) 0.97

Identification of two interaction sites in SecY that are important for the functional interaction with SecA. J Mol Biol (2006) 0.97

In situ assembly of macromolecular complexes triggered by light. Proc Natl Acad Sci U S A (2010) 0.96

Membrane topology of the transporter associated with antigen processing (TAP1) within an assembled functional peptide-loading complex. J Biol Chem (2006) 0.96

Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN. J Am Soc Nephrol (2012) 0.95

Identification of a lysosomal peptide transport system induced during dendritic cell development. J Biol Chem (2007) 0.95

TAP and TAP-like--brothers in arms? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.94

Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proc Natl Acad Sci U S A (2012) 0.94

Bioluminescence imaging allows measuring CD8 T cell function in the liver. Hepatology (2010) 0.93

Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice. Hepatology (2012) 0.93

Kinetics of the ATP hydrolysis cycle of the nucleotide-binding domain of Mdl1 studied by a novel site-specific labeling technique. J Biol Chem (2005) 0.92

Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett (2005) 0.92

Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ. Brain (2012) 0.92